No Detail Found!

Plasma Cell Leukaemia: a Rare Yet Aggressive Plasma Cell Dyscrasia with a very Poor Response to Conventional Therapy.

Author(s)
Najeebullah Khan Northampton General Hospital-,UK
Syed Shahmeer Raza Department of Medicine, Hayatabad Medical Complex, Peshawar- Pakistan
Uzma Ikhtiar Khan Internal Medicine, Khyber Teaching Hospital Peshawar-Pakistan
Hafez Mohammad Ammar Abdullah Internal Medicine, University of South Dakota Sanford School of Medicine-USA
Masroor Hassan Department of Pathology, Rehman Medical Institute Peshawar-,Pakistan
Asfandiar Shah Rukh Hijaz Department of Medicine,Hayatabad Medical Complex, Peshawar- Pakistan
Amer Kamal Hussain Department of Surgery, Hayatabad Medical Complex, Peshawar- Pakistan
Muhammad Daniyal Nadeem Department of Medicine,Hayatabad Medical Complex, Peshawar- Pakistan
Abstract
Plasma cell leukaemia (PCL) is a very rare plasma cell dyscrasia with a significant number of monoclonal plasma cells in the peripheral blood. It is diagnosed by the presence of = 2x109 /L plasma cells in the blood or by plasma cells making up =20% of the leukocyte count. It can arise from a leukemic transformation of multiple myeloma, or more commonly it can be primary. Regardless of its origin, it carries a very dire prognosis. It responds very poorly to the traditional chemotherapy regimens used for multiple myeloma. We present the case of a 50 years old female who presented to our hospital with a complicated UTI and severe generalized body aches. She was diagnosed as a case of plasma cell leukaemia and was treated with cyclophosphamide and dexamethasone, however she failed to go into remission. Her condition deteriorated and she ultimately passed away 1.5 months after diagnosis. The recommended treatment for PCL is aggressive combination chemotherapy followed by stem cell transplantation. However, there is no consensus regarding the treatment of plasma cell leukaemia, and treatment should be individualized based on the patient profile. Once diagnosed, the prognosis is poor.
Publication Details
Page(s) 272-275
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Plasma Cell Dyscrasia, Bortezomib, Multiple Myeloma
0

Citations

0

Downloads

74

Views